Posts tagged ‘Pharma Industry Consulting’
April 19th, 2011
The Food & Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) earlier this year published 5-year data on the number of approvals and applications for new molecular entities (NME) i.e. new products not previously approved.
Pieter Droppert on Biotech Strategy Blog analyzes this data and discusses what we can conclude from it. Pieter also shares his thoughts on some of the challenges facing the biotechnology industry in bringing new products to market, and some of the factors that may be key to success.